Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
Unknown
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Phase 1/2 Unknown
30 enrolled
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
50 enrolled
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Phase NA Unknown
30 enrolled
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Phase 2 Unknown
40 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
Phase 2 Unknown
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
Phase NA Unknown
75 enrolled
Biological Therapy in Treating Women With Metastatic Breast Cancer
Phase 1/2 Unknown
60 enrolled
Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
Phase 2 Unknown
100 enrolled
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Phase 3 Unknown
4,400 enrolled
Tamoxifen in Treating Women With Breast Cancer
Phase 3 Unknown
20,000 enrolled
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer
Phase 2 Unknown
Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
Phase 2 Unknown
Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
Phase 3 Unknown
1,000 enrolled
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
Phase 3 Unknown
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
Phase 1 Unknown
Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
Phase 2 Unknown
Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
Phase 2 Unknown
Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer
Phase 2 Unknown
63 enrolled
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
Phase 2 Unknown
35 enrolled
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
Unknown
1,800 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
A Weight-Loss Program in Helping Obese Black Women Lose Weight
Phase 3 Unknown
200 enrolled
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
Unknown
120 enrolled
Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Phase 1/2 Unknown
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Phase 1/2 Unknown
Combination Chemotherapy in Treating Women With Breast Cancer
Phase 3 Unknown
350 enrolled
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
Phase 3 Unknown
300 enrolled
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
Phase NA Unknown
Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer
Phase NA Unknown
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
Phase 2 Unknown
ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase 2 Unknown
Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer
Phase 2 Unknown
IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
Phase 2 Unknown
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
Phase 1 Unknown
36 enrolled
Temozolomide in Treating Women With Advanced Breast Cancer
Phase 2 Unknown
Hypnosis in Treating Hot Flashes in Breast Cancer Survivors
Phase NA Unknown
60 enrolled
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
Phase 1 Unknown
35 enrolled
Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
Phase NA Unknown
80 enrolled
Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
Phase NA Unknown
54 enrolled
Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
Phase 2 Unknown
60 enrolled
Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
Phase 2 Unknown
100 enrolled
Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase 2 Unknown
160 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer
Phase NA Unknown
20 enrolled
Early Detection of Breast Cancer and Cervical Cancer in Women in India
Phase 2 Unknown
151,538 enrolled
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
Phase 3 Unknown
396 enrolled
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
Unknown
2,300 enrolled
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Unknown